Clostridium difficile-mediated effects on human intestinal epithelia: Modelling host-pathogen interactions in a vertical diffusion chamber

Anaerobe

Volumn 37, Issue , 2016, Pages 96-102

  Jafari, Nazila V ^a,e   Kuehne, Sarah A ^b,c   Minton, Nigel P ^b,c   Allan, Elaine ^d   Bajaj Elliott, Mona ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Auspherix Limited   (United Kingdom)

Author keywords

Antimicrobial immunity; Barrier function; Clostridium difficile infection; Intestinal epithelial cell; Toxins

Indexed keywords

CD14 ANTIGEN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; BACTERIAL TOXIN; CYTOKINE; ENTEROTOXIN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CACO 2 CELL LINE; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DIFFUSION CHAMBER; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; TRANSEPITHELIAL ELECTRICAL RESISTANCE; BIOLOGICAL MODEL; BIOSYNTHESIS; CACO-2 CELL LINE; HEK293 CELL LINE; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE MUCOSA; MICROBIOLOGY; PHYSIOLOGY;

BACTERIAL ADHESION; BACTERIAL TOXINS; CACO-2 CELLS; CLOSTRIDIUM DIFFICILE; CYTOKINES; DIFFUSION CHAMBERS, CULTURE; ENTEROTOXINS; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; INTESTINAL MUCOSA; MODELS, BIOLOGICAL;

EID: 84956957590     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2015.12.007     Document Type: Article

References (29)

1. Bartlett J.G., Moon N., Chang T.W., Taylor N., Onderdonk A.B. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 1978, 75(5):778-782.
2. George R.H., Symonds J.M., Dimock F., Brown J.D., Arabi Y., Shinagawa N., Keighley M.R., Alexander-Williams J., Burdon D.W. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br. Med. J. 1978, 1(6114):695.
3. Beaugerie L., Petit J.C. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best. Pract. Res. Clin. Gastroenterol. 2004, 18(2):337-352.
4. Mahida Y.R. Microbial-gut interactions in health and disease. Epithelial cell responses. Best. Pract. Res. Clin. Gastroenterol. 2004, 18(2):241-253.
5. He M., Sebaihia M., Lawley T.D., Stabler R.A., Dawson L.F., Martin M.J., Holt K.E., Seth-Smith H.M., Quail M.A., Rance R., Brooks K., Churcher C., Harris D., Bentley S.D., Burrows C., Clark L., Corton C., Murray V., Rose G., Thurston S., van T.A., Walker D., Wren B.W., Dougan G., Parkhill J. Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(16):7527-7532.
6. Kim J.M., Kim J.S., Jun H.C., Oh Y.K., Song I.S., Kim C.Y. Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A. Microbiol. Immunol. 2002, 46(5):333-342.
7. Johal S.S., Solomon K., Dodson S., Borriello S.P., Mahida Y.R. Differential effects of varying concentrations of Clostridium difficile toxin A on epithelial barrier function and expression of cytokines. J. Infect. Dis. 2004, 189(11):2110-2119.
8. Seok H., Nam H.J., Nam S.T., Kang J.K., Kim S.K., Chang J.S., Ha E.M., Park Y.J., Kim H. Clostridium difficile toxin A inhibits the kinase activity of extracellular signal-related kinases 1 and 2 through direct binding. J. Microbiol. Biotechnol. 2012, 22(2):170-175.
9. Bobo L.D., El Feghaly R.E., Chen Y.S., Dubberke E.R., Han Z., Baker A.H., Li J., Burnham C.A., Haslam D.B. MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect. Immun. 2013, 81(3):713-722.
10. Drudy D., O'Donoghue D.P., Baird A., Fenelon L., O'Farrelly C. Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells. J. Med. Microbiol. 2001, 50(6):526-534.
11. Calabi E., Calabi F., Phillips A.D., Fairweather N.F. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect. Immun. 2002, 70(10):5770-5778.
12. Ryan A., Lynch M., Smith S.M., Amu S., Nel H.J., McCoy C.E., Dowling J.K., Draper E., O'Reilly V., McCarthy C., O'Brien J., Ni E.D., O'Connell M.J., Keogh B., Morton C.O., Rogers T.R., Fallon P.G., O'Neill L.A., Kelleher D., Loscher C.E. A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog. 2011, 7(6):e1002076.
13. Jarchum I., Liu M., Lipuma L., Pamer E.G. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect. Immun. 2011, 79(4):1498-1503.
14. Jafari N.V., Kuehne S.A., Bryant C.E., Elawad M., Wren B.W., Minton N.P., Allan E., Bajaj-Elliott M. Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s). PLoS One 2013, 8(7):e69846.
15. Kuehne S.A., Collery M.M., Kelly M.L., Cartman S.T., Cockayne A., Minton N.P. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J. Infect. Dis. 2014, 209(1):83-86.
16. Jafari N.V., Songane M., Stabler R.A., Elawad M., Wren B.W., Allan E., Bajaj-Elliott M. Host immunity to Clostridium difficile PCR ribotype 017 strains. Infect. Immun. 2014, 82(12):4989-4996.
17. Kagnoff M.F., Eckmann L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 1997, 100(1):6-10.
18. Borriello S.P., Welch A.R., Barclay F.E., Davies H.A. Mucosal association by Clostridium difficile in the hamster gastrointestinal tract. J. Med. Microbiol. 1988, 25(3):191-196.
19. Schwan C., Stecher B., Tzivelekidis T., van H.M., Rohde M., Hardt W.D., Wehland J., Aktories K. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS.Pathog. 2009, 5(10):e1000626.
20. Li X., Jiang S., Tapping R.I. Toll-like receptor signaling in cell proliferation and survival. Cytokine 2010, 49(1):1-9.
21. Nusrat A., von Eichel-Streiber C., Turner J.R., Verkade P., Madara J.L., Parkos C.A. Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins. Infect. Immun. 2001, 69(3):1329-1336.
22. Savidge T.C., Pan W.H., Newman P., O'brien M., Anton P.M., Pothoulakis C. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology 2003, 125(2):413-420.
23. Sutton P.A., Li S., Webb J., Solomon K., Brazier J., Mahida Y.R. Essential role of toxin A in Clostridium difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function. Clin. Exp. Immunol. 2008, 153(3):439-447.
24. Deneve C., Janoir C., Poilane I., Fantinato C., Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int. J. Antimicrob. Agents 2009, 33(Suppl. 1):S24-S28.
25. Fagan R.P., Albesa-Jove D., Qazi O., Svergun D.I., Brown K.A., Fairweather N.F. Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol. Microbiol. 2009, 71(5):1308-1322.
26. Dingle K.E., Didelot X., Ansari M.A., Eyre D.W., Vaughan A., Griffiths D., Ip C.L., Batty E.M., Golubchik T., Bowden R., Jolley K.A., Hood D.W., Fawley W.N., Walker A.S., Peto T.E., Wilcox M.H., Crook D.W. Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J. Infect. Dis. 2013, 207(4):675-686.
27. Feltis B.A., Wiesner S.M., Kim A.S., Erlandsen S.L., Lyerly D.L., Wilkins T.D., Wells C.L. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes. Shock 2000, 14(6):629-634.
28. Hecht G., Pothoulakis C., LaMont J.T., Madara J.L. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J. Clin. Invest. 1988, 82(5):1516-1524.
29. Halabi-Cabezon I., Huelsenbeck J., May M., Ladwein M., Rottner K., Just I., Genth H. Prevention of the cytopathic effect induced by Clostridium difficile toxin B by active Rac1. FEBS Lett. 2008, 582(27):3751-3756.